• Explore /
  • Poster
  • / Pan tumor outcomes to immune checkpoint inhibitors in patients of Native American origin in the United States: The multicenter POINT-US study.

Pan tumor outcomes to immune checkpoint inhibitors in patients of Native American origin in the United States: The multicenter POINT-US study.

Abstract Poster

Authors

null

Minh Duc Phan

Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK

Minh Duc Phan , Paul Antoine El Tomb , Tariq Khreis , Tobias Meissner , Rachel Elsey , Bing Xu , Junaid Arshad , Umbreen Arshad Rozell , Elysia Tjong , Vaia Florou , Sonam Puri , Arsalan Khan , Dorothy Rhoades , Raid Aljumaily , Adanma Ayanambakkam , Anthony Burtman , Mark Bigbey , Michael Sjoquist , Casey B. Williams , Abdul Rafeh Naqash

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Other IO-Related Topics

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 2654)

DOI

10.1200/JCO.2023.41.16_suppl.2654

Abstract #

2654

Poster Bd #

496

Abstract Disclosures

Similar Posters

First Author: Koichi Azuma

First Author: Dharmesh Gopalakrishnan

First Author: Takaya Ikeda

First Author: Lin Wu